Your browser doesn't support javascript.
loading
Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer.
Möller, Katharina; Fraune, Christoph; Blessin, Niclas C; Lennartz, Maximilian; Kluth, Martina; Hube-Magg, Claudia; Lindhorst, Linnea; Dahlem, Roland; Fisch, Margit; Eichenauer, Till; Riechardt, Silke; Simon, Ronald; Sauter, Guido; Büscheck, Franziska; Höppner, Wolfgang; Matthies, Cord; Doh, Ousman; Krech, Till; Marx, Andreas H; Zecha, Henrik; Rink, Michael; Steurer, Stefan; Clauditz, Till S.
Afiliação
  • Möller K; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Fraune C; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Blessin NC; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Lennartz M; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Kluth M; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Hube-Magg C; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Lindhorst L; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Dahlem R; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Fisch M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Eichenauer T; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Riechardt S; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Simon R; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany. R.Simon@uke.de.
  • Sauter G; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Büscheck F; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Höppner W; Department of Urology, Itzehoe Medical Center, Itzehoe, Germany.
  • Matthies C; Department of Urology, Bundeswehr Hospital Hamburg, Hamburg, Germany.
  • Doh O; Department of Urology, Regio Medical Center Elmshorn, Elmshorn, Germany.
  • Krech T; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Marx AH; Institute of Pathology, Clinical Center Osnabrueck, Osnabrück, Germany.
  • Zecha H; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Rink M; Department of Pathology, Academic Hospital Fuerth, Fuerth, Germany.
  • Steurer S; Department of Urology, Albertinen Clinic, Hamburg, Germany.
  • Clauditz TS; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Int Urol Nephrol ; 53(12): 2493-2503, 2021 Dec.
Article em En | MEDLINE | ID: mdl-33797012

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antígeno B7-H1 / Neoplasias Renais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antígeno B7-H1 / Neoplasias Renais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article